Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

MUNICH, Germany, September 3 /PRNewswire/ --

A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new or recurrent heart attacks (7.4 percent vs. 9.7 percent, p<0.0001), regardless of whether the events occurred around the time of an artery-opening procedure known as percutaneous coronary intervention (PCI), or if they occurred spontaneously during the longer-term maintenance phase. The analysis was presented today at the European Society of Cardiology (ESC) in Munich, Germany.

MILPITAS, California, September 3 /PRNewswire/ --

- Industry's First and Only RAID Controller-Based Power Management Solution for SATA and SAS Storage

To significantly increase the energy efficiency of disk-based storage, Adaptec Inc. (Nasdaq: ADPT), a global leader in storage solutions, today kicked off its Green Power initiative with the introduction of Adaptec Intelligent Power Management, a new capability that allows system OEMs, integrators and IT managers to easily custom-configure storage systems to reduce power consumption by up to 70 per cent without sacrificing performance. Intelligent Power Management is now integrated into all Adaptec's high-performance, award-winning Series 5 and Series 2 Unified Serial(TM) RAID controllers.

GRONINGEN, The Netherlands, September 3 /PRNewswire/ -- The Groningen-based internet company Baidu Europe is selling its highly sought-after brand and domain names. As well as the brand name Baidu, the domain names for sale include baidu.eu, baidu.tv, baidu.nl and baidu.be. Managing Director P. Ufkes of Baidu Europe is taking this step in response to the difficulties his company has faced since a Dutch agency began to promote the Chinese search engine giant Baidu in Europe. Ufkes plans to continue his company under a different name.

LONDON, September 3 /PRNewswire/ -- Travelzoo (NASDAQ: TZOO), a global Internet media company, today announced that its European publications now reach an audience of over two million weekly unduplicated subscribers. Publications include the Travelzoo Top 20(TM) list in the UK, France, Germany and Spain and Newsflash, a regionally targeted travel alert service available in 17 local markets across Europe. In the last 12 months, one million new European subscribers have signed up to receive Travelzoo email publications, doubling Travelzoo's European reach.

Active unduplicated weekly subscribers by market are now: 1,050,000 in the UK; 575,000 in France; 355,000 in Germany and 80,000 in Spain.

PARIS, September 3 /PRNewswire/ --

- This Analysis Showed That Multaq(R) (Dronedarone) Decreased the Risk of Stroke by 34% in Patients With Atrial Fibrillation or Atrial Flutter Already Adequately Treated by Antithrombotic Therapy

The results of a post-hoc analysis of the data from the ATHENA study were presented today at the clinical trial update session of the European Society of Cardiology congress 2008, in Munich, Germany. Previous results from the landmark ATHENA study have shown that the investigational medicine Multaq(R) (dronedarone) on top of standard therapy decreased the combined primary endpoint of the risk of cardiovascular hospitalisations or death from any cause by a statistically significant 24% (p=0.00000002) as compared to placebo.

KIRKLAND, Washington and DUSSELDORF, Germany, September 3 /PRNewswire/ --

- Hires GM Europe and Vice President of Marketing

INRIX(R), the leading provider of traffic information, today announced two significant additions to its executive management team and the opening of its European headquarters. Hans-Hendrik Puvogel, formerly CEO of Jentro Technologies, is joining INRIX as general manager Europe and is responsible for establishing the company's European headquarters in Dusseldorf, Germany. Chris Hamer, a seasoned marketing executive at OnStar, Cadillac and priceline.com, is joining INRIX as vice president of marketing.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080903/AQW095) (Logo: http://www.newscom.com/cgi-bin/prnh/20060424/SFM077LOGO-b)